Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study (Gramling, et al, 2023)

13 feb.

Escrito por Michael DeMarco, therapist

Michael DeMarco, therapist

Psychedelic therapist, clinical sexologist, and Founding Fellow of Psychedelic Institute of Mental Health and Family Therapy

https://psychedelicmentalhealth.net/michael-demarco-therapist

Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms (Nikolaidis, et al, 2023)

Ketamine’s Role in Spirituality: How One Synthetic Drug Catalyzes a Natural Experience (Woods, 2020)